{"id":5514,"date":"2024-04-16T03:14:30","date_gmt":"2024-04-16T03:14:30","guid":{"rendered":"https:\/\/tb.org.tw\/aprc2024\/?page_id=5514"},"modified":"2024-04-19T06:26:37","modified_gmt":"2024-04-19T06:26:37","slug":"oral-presentation-schedule","status":"publish","type":"page","link":"https:\/\/tb.org.tw\/aprc2024\/?page_id=5514","title":{"rendered":"Oral Presentation Schedule"},"content":{"rendered":"

\nHome<\/a><\/span> \/\nAbstract & Awards<\/a><\/span> \/\nOral Presentation Schedule<\/span>\n<\/div><\/div><\/div>
\n
\n
Oral Presentation 1<\/h5>\n

Category: Respiratory Tract Infection- Nontuberculous Mycobacteria, Fungal Infection, and Critical Care Medicine<\/p>\n<\/div>\n

Date: Saturday, Apr 27, 2024 | Time: 13:30-14:40 (GMT+8)
\nLocation: 2F \/ Room 201 AF
\nModerator: Dr. Shih-Wei Lee (Taiwan)<\/a> | Prof. Kuo-Chin Kao (Taiwan)<\/a><\/div>\n<\/div>\n<\/div>\n
\n\n\n\n\n\n\n\n\n\n\n\n
Presentation Serial Number<\/strong><\/th>\nTitle<\/strong><\/th>\nPresenter<\/strong><\/th>\n<\/tr>\n<\/thead>\n
OP-01-01<\/td>\nEXOSOMAL SIGNALS OF PATIENTS WITH NONTUBERCULOUS MYCOBACTERIAL LUNG DISEASE REDUCE HOST IMMUNITY<\/td>\nDr. Chin-Chung Shu<\/td>\n<\/tr>\n
OP-01-02<\/td>\nWHETHER CLINICAL MANIFESTATIONS OF NONTUBERCULOUS MYCOBACTERIA PULMONARY DISEASE DIFFER IF COEXISTENCE OF OTHER NTM SPECIES?<\/td>\nDr. Chia-Ling Chang<\/td>\n<\/tr>\n
OP-01-03<\/td>\nFINDING THE OPTIMAL REGIMEN FOR MYCOBACTERIUM ABSCESSUS TREATMENT (FORMAT TRIAL) – AN OUTLINE OF THE FIRST RANDOMISED CONTROL TRIAL FOR M.ABSCESSUS.<\/td>\nDr. Andrew Burke<\/td>\n<\/tr>\n
OP-01-04<\/td>\nDEVELOPING A DEEP LEARNING MODEL WITH CHEST COMPUTED TOMOGRAPHY IMAGES TO DISTINGUISH BETWEEN NONTUBERCULOUS MYCOBACTERIAL PULMONARY DISEASE AND COLONIZATION: MULTI-CENTER VALIDATION STUDY<\/td>\nDr. Chia-Jung Liu<\/td>\n<\/tr>\n
OP-01-05<\/td>\nTHE CLINICAL SPECTRUM AND SEROPREVALENCE OF ASPERGILLUS IGG IN CHRONIC PULMONARY DISEASE: A PROSPECTIVE STUDY<\/td>\nDr. Geng-Ning Hu<\/td>\n<\/tr>\n
OP-01-06<\/td>\nHYPOGLYCEMIA DURING ICU STAY IS ASSOCIATED WITH INCREASED RISK OF ONE-YEAR DEATH IN CRITICAL ILL PATIENTS<\/td>\nDr. I-Hung Lin<\/td>\n<\/tr>\n
OP-01-07<\/td>\nINNOVATIVE INHALATION THERAPY USING PLGA ENCAPSULATED FTY720 AND NOBILETIN FOR LIPOPOLYSACCHARIDE-INDUCED LUNG INJURY, EMPOWERED BY INHALATION TOWER TECHNOLOGY<\/td>\nDr. Chien-Chung Lin<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n